{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:33:01Z","timestamp":1761323581419,"version":"3.35.0"},"reference-count":15,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":9012,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1993,5]]},"abstract":"<jats:p>A 67-year-old man developed concurrent severe agranulocytosis and elevation of hepatic transaminases as a result of treatment with clomipramine. Although such adverse drug reactions can be considered rare events, the potentially serious nature of these reactions vindicate the routine monitoring of blood picture, and liver function tests, after initiation of treatment with tricyclic antidepressants.<\/jats:p>","DOI":"10.1192\/bjp.162.5.688","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T05:21:28Z","timestamp":1224048088000},"page":"688-689","source":"Crossref","is-referenced-by-count":11,"title":["Concurrent Agranulocytosis and Hepatitis Secondary to Clomipramine Therapy"],"prefix":"10.1192","volume":"162","author":[{"given":"Christopher P.","family":"Alderman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Atchison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet I.","family":"McNeece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000032773_ref15","first-page":"211","article-title":"The hepatic injury of monoamine oxidase inhibitors","volume":"7","author":"Zimmerman","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"S0007125000032773_ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100208"},{"key":"S0007125000032773_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90016-5"},{"key":"S0007125000032773_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/106002808201600110"},{"key":"S0007125000032773_ref7","doi-asserted-by":"publisher","DOI":"10.1177\/070674378603100712"},{"key":"S0007125000032773_ref6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5694\/j.1326-5377.1987.tb120347.x","article-title":"Neutropenia with crossintolerance between two tricyclic antidepressant agents","volume":"146","author":"Draper","year":"1987","journal-title":"Medical Journal of Australia"},{"key":"S0007125000032773_ref5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5694\/j.1326-5377.1982.tb132486.x","article-title":"Agranulocytosis associated with dothiepin","volume":"ii","author":"Doery","year":"1982","journal-title":"Medical Journal of Australia"},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1967","key":"S0007125000032773_ref2"},{"key":"S0007125000032773_ref1","first-page":"483","article-title":"Agranulocytosis associated with tricyclics","volume":"39","author":"Albertino","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000032773_ref12","doi-asserted-by":"publisher","DOI":"10.1520\/JFS12732J"},{"key":"S0007125000032773_ref13","first-page":"4","article-title":"Are receptor studies useful for clinical practice?","volume":"44","author":"Richelson","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000032773_ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6160.378"},{"key":"S0007125000032773_ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.6.726"},{"key":"S0007125000032773_ref3","first-page":"673","article-title":"Mianserin: a possible cause of neutropenia and agranulocytosis","volume":"ii","year":"1980","journal-title":"Medical Journal of Australia"},{"key":"S0007125000032773_ref14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/j.1875-9114.1990.tb02551.x","article-title":"Hepatic failure associated with imipramine therapy","volume":"10","author":"Shaefer","year":"1990","journal-title":"Pharmacotherapy"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000032773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:21:47Z","timestamp":1738437707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000032773\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["S0007125000032773"],"URL":"https:\/\/doi.org\/10.1192\/bjp.162.5.688","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"type":"print","value":"0007-1250"},{"type":"electronic","value":"1472-1465"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}